Semi-Solid Pharmaceutical Texture Analysis: Gels, Ointments & Creams

Semi-solid pharmaceutical texture analysis is the instrumented measurement of mechanical and rheological properties — firmness, cohesiveness, adhesiveness, springiness and spreadability — of topical drug products such as gels, ointments, creams and pastes, using a texture analyzer under controlled speed, distance and temperature. In a pharmaceutical QC laboratory, the pharmaceutical gel spreadability test and related semi-solid methods support product development, in-process control, batch release and stability monitoring under USP <1724> Semi-Solid Drug Products — Performance Tests, EP 2.9 general methods and 21 CFR Part 211 GMP requirements. On a texture analyzer such as the KHT TA-30, a single instrument with interchangeable fixtures covers the full semi-solid toolbox: spreadability rig, back extrusion cell, cone penetrometer and TPA double-compression — from 0.01 N peak force hydrogels to 50 N stiff anhydrous ointments.

Why Semi-Solid Texture Analysis Is Critical for Formulation Development

Topical semi-solids are uniquely difficult to characterise. Unlike a tablet, where a single hardness value summarises mechanical behaviour, a pharmaceutical cream or ointment is a multiphase system — an emulsion, a hydrogel or a hydrocarbon base loaded with dispersed API — whose patient-perceived consistency, drug release and clinical acceptability depend on viscoelastic behaviour at shear rates the patient applies with a fingertip. Rheometry captures part of this story, but cannot reproduce the finite-strain, non-linear deformation that happens when a cream is squeezed from a tube or rubbed onto skin. This is where a texture analyzer becomes the formulation scientist's primary tool.

During formulation development, texture parameters correlate directly with sensorial descriptors that clinical subjects report: firmness with "heaviness", adhesiveness with "stickiness", cohesiveness with "body" or "richness", spreadability with "glide". An anti-fungal cream that is too firm leaves patches un-treated. An ophthalmic gel that is too cohesive will not distribute across the eye. A vaginal gel with insufficient adhesiveness fails its residence time requirement. Every one of these failure modes can be screened on a texture analyzer in minutes, using sample sizes of 20–50 g, long before an expensive clinical or bioequivalence study.

In QC, the role shifts from discovery to discrimination. Here the texture analyzer provides an objective, number-based check that today's batch behaves like the reference batch. Because semi-solids are sensitive to mixing shear, cooling rate, and component ratio, subtle process drift — a slower homogeniser, a warmer cooling bath, a slightly under-charged wax — produces a reliable signature on the texture profile. Firmness typically drifts by 10–30% before it is detectable by trained visual inspection. Peak force resolution of 0.01 N, as delivered by the KHT TA-30, is therefore not a vanity spec: it is the difference between catching the drift at in-process control or shipping a rejectable batch.

Finally, the regulatory environment has tightened. USP <1724> explicitly recognises instrumented texture analysis as an acceptable performance test for semi-solids, and the FDA's current thinking on topical generic bioequivalence increasingly relies on in-vitro comparators including rheology and texture to support Q3 (microstructure) equivalence. A validated texture method, run on a 21 CFR Part 11-compliant analyzer, is now a line item on most modern topical drug product specifications.

Key Parameters: Spreadability, Firmness, Cohesiveness & Adhesiveness

Semi-solid texture analysis relies on a small, well-defined family of numerical parameters, most extracted directly from the force-time or force-distance curve. The table below summarises the five most important parameters, the test geometries that produce them, and typical ranges measured on the KHT TA-30.

Other secondary parameters — stickiness, gumminess, resilience, work of shear — are occasionally specified, particularly for mucoadhesive or bioadhesive gels. The force range encountered across these tests spans 0.01 N (a low-viscosity hydrogel being penetrated by a cone) to ~50 N (an anhydrous petrolatum ointment at 20 °C under a back extrusion disc). A texture analyzer with a single 5 kg load cell and 0.01 N resolution, such as the KHT TA-30, can handle this full window without load cell changes — a meaningful operational advantage over budget instruments that require a dedicated low-force cell for hydrogels and a separate cell for stiff ointments.

Test Methods Overview: Cone Penetration, Spreadability Rig & TPA

Four test geometries cover virtually all semi-solid pharmaceutical work. Each produces a distinctive force-distance signature and a distinct slate of derived parameters.

1. Spreadability rig (Ortan method / 45° or 90° cone). A male cone is driven into a female cone filled with product. The work performed on the material — the area under the force-distance curve during the downstroke — is defined as "spreadability energy" in units of N·mm. This is the most sensitive geometry for topical gels, because it reproduces the finite-thickness shear that occurs when a fingertip spreads product on skin. Spreadability rigs are available in 45° (firmer products) and 90° (softer products) geometries. For the pharmaceutical gel spreadability test, the 90° cone is the de-facto standard. Full protocol: see our pharmaceutical gel spreadability test page.

2. Back extrusion cell. A flat disc, typically 35 or 45 mm in diameter, is driven at a controlled speed into a cylindrical cell filled with product. The annular gap between disc and cell wall forces the product to flow upward past the disc, creating a steady-state extrusion force that correlates with apparent viscosity. Back extrusion is the preferred method for thick ointments (petrolatum bases, zinc oxide pastes) where a cone cannot be driven to full depth without side leakage. Detailed method: see ointment texture analysis.

3. Cone penetrometry (ASTM D217-equivalent). A standard cone (typically 45°) falls under its own weight or is driven at a controlled speed into the sample for a fixed time. Penetration depth (for free-fall) or peak force (for driven cone) correlates with apparent yield stress. Cone penetrometry is the classical ointment test cited in ASTM D217 and is carried forward by pharmacopoeial practice for hydrocarbon ointments and medicated petrolatum bases.

4. Texture Profile Analysis (TPA). Two sequential compression cycles are applied to the sample at a controlled strain (typically 30–70% of product height) with a defined dwell between bites. From the two force-distance curves, five parameters are extracted: hardness (peak force of first bite), cohesiveness (A2 / A1), springiness (distance ratio), gumminess (hardness × cohesiveness, only meaningful for semi-solids) and adhesiveness (negative area during first withdrawal). TPA is the most information-rich single test for pharmaceutical creams and is the workhorse of batch-to-batch consistency QC. See our cream consistency texture analysis page for the detailed TPA protocol.

A well-designed semi-solid texture analyzer supports all four methods with interchangeable fixtures on a single base instrument. One of the most common cost traps in budget instruments — and one of the reasons KHT publishes fixture pricing transparently — is that a cheap analyzer often supports only one or two of these four geometries, locking the lab out of the most appropriate test for half of its product portfolio.

Regulatory Expectations for Semi-Solid Texture Testing

Three layers of regulation frame semi-solid texture analysis in a pharmaceutical laboratory.

USP <1724> — Semi-Solid Drug Products — Performance Tests. Chapter <1724> is the primary USP reference for semi-solid performance testing. Although its central focus is in-vitro release testing (IVRT) using vertical diffusion cells, the chapter explicitly discusses rheological and texture measurements as supportive characterisation, including apparent viscosity, yield stress, and consistency. For topical generic submissions, FDA guidance on establishing Q3 (microstructural) sameness to the reference listed drug increasingly expects texture parameters as part of the comparative data package.

EP 2.9 general methods and EP monographs. The European Pharmacopoeia does not publish a dedicated semi-solid texture chapter, but many product monographs and the general chapter on semi-solid preparations cross-reference "consistency" as a quality attribute. In practice, European labs cite EP 2.9 general provisions and supplement with ISO standards (ISO 2137 for cone penetrometry) and in-house validated methods.

21 CFR Part 211 & 21 CFR Part 11. US GMP requires written test methods, validated instruments, documented calibrations and electronic-record integrity. For a texture analyzer running semi-solid release tests, this translates into four practical requirements: (1) method validation per ICH Q2 for accuracy, precision, robustness and intermediate precision; (2) qualification of the instrument through IQ/OQ/PQ; (3) 21 CFR Part 11-compliant software for electronic records and signatures (audit trail, user access control, archival); and (4) SOPs for calibration and preventive maintenance.

A compliance gap that still surprises many pharmaceutical buyers: enterprise brands often ship 21 CFR Part 11 functionality as an optional "advanced software edition", adding four- or five-figure line items to the quote. Budget brands frequently do not offer it at all. The KHT TA-30 ships with 21 CFR Part 11-compliant software as standard, and the GMP validation package (IQ/OQ/PQ templates) is included in the purchase price — eliminating one of the highest-friction line items in pharmaceutical QC procurement.

Selecting the Right Probe and Cell for Your Semi-Solid Product

Fixture selection is the single most frequent source of method error in semi-solid texture analysis. A simple rule of thumb:

• Low-viscosity aqueous gels and hydrogels (0.1–2 N peak force): 90° spreadability rig for spreadability; 10 mm cylindrical probe into a 35 mm back extrusion cell for in-cell testing.
• Hydroalcoholic gels and mucoadhesive gels: 45° or 90° spreadability rig for spreadability; TPA with a 25 mm flat cylindrical probe for bulk consistency.
• O/W emulsion creams (1–8 N peak force): TPA with a 25 mm or 35 mm flat probe for firmness/cohesiveness/adhesiveness; 45° spreadability rig for consumer-perceived spread.
• W/O emulsion creams and oleaginous bases: back extrusion cell (45 mm disc into 50 mm cell) is more repeatable than a flat probe, because the stiff matrix tends to fracture rather than compress.
• Anhydrous ointments and petrolatum-based products (5–50 N peak force): back extrusion cell as primary; cone penetrometry as secondary. A 5 kg load cell with 0.01 N resolution covers the full range; instruments capped at 500 g may over-range on stiff ointments.
• Pastes (zinc oxide, sulphur pastes): back extrusion cell with larger annular gap, or a 12 mm needle probe for yield stress.

A note on temperature. Semi-solid texture is strongly temperature-dependent. Many formulations soften by 15–30% per 5 °C rise. For pharmacopoeial work and bioequivalence studies, conditioning at 25.0 ± 0.5 °C is essential. The KHT TA-30 supports Peltier-controlled platforms for tests at 32 °C (skin simulation) or 37 °C (body temperature), which is particularly relevant for transdermal and ophthalmic products.

For a full fixture decision matrix across all 30+ semi-solid dosage forms in the KHT method library, see the probe selection guide. For a specification comparison, see the KHT TA-30 product page.

Test Method Details

Each of the four primary semi-solid test methods relies on a specific fixture set. The table below summarises the fixture, force range and typical test parameters used on the KHT TA-30 for routine pharmaceutical semi-solid work.

Key TPA Parameters for Semi-Solids

TPA produces the most information from a single test and is the parameter set cited in most pharmaceutical specifications. The table below gives typical ranges for pharmaceutical semi-solids on the KHT TA-30 with a 25 mm flat probe, 50% strain, 5 s inter-bite dwell, and 1.0 mm/s test speed.

Budget texture analyzers that cannot run complete TPA double-compression curves — a real limitation in several sub-$5,000 instruments — leave the laboratory restricted to single-bite peak force data. For routine semi-solid QC work, that is a significant handicap. The KHT TA-30 runs full TPA with user-configurable strain, speed, dwell and trigger thresholds, and exports the parameter table directly to a 21 CFR Part 11-compliant record.

Step-by-Step Protocol

The following generic protocol sets up the KHT TA-30 for semi-solid performance testing. Product-specific protocols for gels, ointments and creams are provided on the corresponding detail pages.

1. Sample preparation. Condition 20–50 g of product at 25.0 ± 0.5 °C for at least 4 hours. Transfer to the test container (back extrusion cell, cylindrical vial, or spreadability rig female cone) avoiding air entrapment.
2. Load cell and fixture selection. Fit the 5 kg load cell. Install the fixture appropriate to the method (see table above). Tare the load cell with the fixture attached.
3. Method setup. In the KHT TA-30 software, select the pre-built template for the product class (gel, cream or ointment) or create a new method. Typical parameters: pre-test speed 2.0 mm/s, test speed 1.0 mm/s, post-test speed 10 mm/s, trigger force 0.05 N, data acquisition 500 Hz.
4. Calibrate zero and height. Run the automatic zero-distance routine: the fixture descends at post-test speed until the trigger force is detected, then records that position as the sample surface reference.
5. Execute test. Start the method. The instrument will perform compression, optional dwell, withdrawal (and, for TPA, a second compression cycle). Data acquisition records force and distance at 500 Hz.
6. Parameter extraction. The software automatically integrates the curves and reports the parameter table (firmness, cohesiveness, springiness, adhesiveness, spreadability energy as appropriate).
7. Replicate and report. Run five replicates per sample. Report mean ± SD and %RSD. For routine QC, %RSD should remain below 10% for firmness and 15% for adhesiveness.
8. Document. Save the method and results to the 21 CFR Part 11 audit trail with user ID, date/time stamp, and electronic signature. Include the record in the batch documentation.